# Openevidence - PE Due Diligence Dashboard

**Generated**: 2025-11-21 11:45:30 UTC

---

## 1. Company Overview
Openevidence, founded in 2020, is headquartered in the United States and operates within the medical information technology sector. The company emerged from the Mayo Clinic Platform Accelerate program, aiming to address the challenges posed by the overwhelming volume of medical research published annually, which is doubling every five years. Openevidence's mission is to organize and expand the world's collective medical knowledge, providing healthcare professionals with the tools necessary to navigate and synthesize clinical findings effectively.

The leadership team includes notable figures from various medical backgrounds, such as Dr. Forte, MD, PhD, and Dr. Leonard Calabrese, DO, among others, who bring extensive expertise in their respective fields. This diverse leadership is indicative of the company's commitment to integrating clinical insights into its platform, thereby enhancing its credibility and relevance in the healthcare sector.

## 2. Business Model and GTM
Openevidence operates primarily as a B2B platform, targeting healthcare professionals, including physicians and medical researchers. The platform aggregates, synthesizes, and visualizes clinically relevant evidence, making it easier for users to access critical information. The service is offered for free to verified U.S. healthcare professionals, which is a strategic move to increase user adoption and engagement.

The go-to-market strategy leverages partnerships with reputable medical journals such as The New England Journal of Medicine and JAMA, enhancing the platform's content quality and credibility. Competitive positioning is strengthened through its unique focus on addressing the information overload in the medical field, setting it apart from traditional medical search engines.

## 3. Funding & Investor Profile
Openevidence has successfully raised a total of $50 million across several funding rounds since its inception. Key investors include prominent venture capital firms such as Sequoia, Google Ventures, Kleiner Perkins, and Blackstone, among others. The latest funding round occurred in early 2023, although specific amounts and dates for each round are not disclosed. The investor composition reflects a strong backing from both technology and healthcare-focused entities, indicating confidence in Openevidence's potential for growth and innovation.

## 4. Growth Momentum
The company has shown promising growth momentum, with a notable increase in headcount as it expands its operations. While specific hiring trends and office locations are not disclosed, the expansion of partnerships and product offerings suggests a proactive approach to scaling its business. The platform's user engagement is expected to grow as it continues to enhance its capabilities, particularly in synthesizing and visualizing medical data.

## 5. Visibility & Market Sentiment
Openevidence has garnered positive visibility in the healthcare technology space, with mentions in various medical and technology publications. The platform's innovative approach to managing medical information has been recognized, although specific awards or recognitions are not detailed. User sentiment appears favorable, as evidenced by its free access model for healthcare professionals, which likely contributes to a positive public perception.

## 6. Risks and Challenges
Despite its strengths, Openevidence faces several risks and challenges. The competitive landscape includes established players in medical information and search technologies, which may pose threats to market share. Operational challenges related to data security and compliance with regulations such as HIPAA are critical, given the sensitive nature of healthcare data. Additionally, the rapid pace of medical research necessitates continuous updates and improvements to the platform, which can strain resources.

## 7. Outlook
Looking ahead, Openevidence is well-positioned to capitalize on the growing need for efficient medical information management solutions. Opportunities for growth include expanding its user base beyond the U.S. and enhancing its platform features to include more advanced analytics and personalized content delivery. Strategic initiatives may involve deeper collaborations with healthcare institutions and further integration of AI technologies to improve user experience and data synthesis capabilities.

## 8. Disclosure Gaps
Several key metrics and information remain undisclosed, including specific revenue figures, detailed customer counts, and the exact valuation of the company post-funding rounds. Additionally, insights into the company's hiring trends and specific office locations are not available, limiting a comprehensive understanding of its operational scale and workforce dynamics. 

---